SyntekaBio Inc (226330) — Cash Flow Quality Index
Latest as of June 2024:
-2.40x
SyntekaBio Inc (226330) has a Cash Flow Quality Index of -2.40x as of June 2024. Operating cash flow of ₩-1.63 Billion is below net income of ₩677.08 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 226330 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-2.40x
Operating CF / Net Income
Operating Cash Flow
₩-1.63 Billion
KRW
Net Income
₩677.08 Million
KRW
Data as of
Jun 2024
Most recent filing
SyntekaBio Inc Cash Flow Quality Index (2018–2018)
Historical Cash Flow Quality Index for SyntekaBio Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does SyntekaBio Inc generate cash.
Annual Cash Flow Quality Index for SyntekaBio Inc (2018–2018)
Year-by-year earnings quality comparison for SyntekaBio Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | -0.63x | ₩-2.37 Billion | ₩3.75 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.